Brunilda Shtylla is Chief Business Officer of SUTRO BIOPHARMA, INC.. Currently has a direct ownership of 0 shares of STRO, which is worth approximately $0. The most recent transaction as insider was on Aug 28, 2023, when has been sold 15,428 shares (Common Stock) at a price of $4.71 per share, resulting in proceeds of $72,665. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Brunilda Shtylla Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 28 2023
SELL
Open market or private sale
$72,665 $4.71 p/Share
15,428 Reduced 100.0%
0 Common Stock
Aug 25 2023
SELL
Open market or private sale
$53,303 $4.59 p/Share
11,613 Reduced 47.32%
12,928 Common Stock
Mar 03 2023
SELL
Payment of exercise price or tax liability
$26,263 $5.79 p/Share
4,536 Reduced 15.08%
25,541 Common Stock
Mar 03 2023
BUY
Exercise of conversion of derivative security
-
11,125 Added 27.67%
29,077 Common Stock
BS

Brunilda Shtylla

Chief Business Officer
South San Francisco, CA

Track Institutional and Insider Activities on STRO

Follow SUTRO BIOPHARMA, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells STRO shares.

Notify only if

Insider Trading

Get notified when an Sutro Biopharma, Inc. insider buys or sells STRO shares.

Notify only if

News

Receive news related to SUTRO BIOPHARMA, INC.

Track Activities on STRO